<DOC>
	<DOCNO>NCT01094977</DOCNO>
	<brief_summary>The primary objective study investigate whether tranexamic acid ( TXA ) reduce perioperative blood loss transfusion requirement infant undergo craniosynostosis surgery .</brief_summary>
	<brief_title>Blood Loss Transfusion Requirement Infants Treated With Tranexamic Acid</brief_title>
	<detailed_description>Blood loss pediatric craniosynostosis surgery significant may exacerbate dilutional coagulopathy . Multimodal blood conservation strategy may limit allogeneic transfusion , although RCTs limit . It essential investigate technique determine potential reduce allogeneic blood transfusion associate cost morbidity . Tranexamic acid ( TXA ) synthetic antifibrinolytic drug competitively inhibit lysine bind site plasminogen , plasmin , tissue plasminogen activator . The result inhibition fibrinolysis clot degradation . Recent study adults undergoing cardiac surgery demonstrate people different genotype plasminogen activator inhibitor-1 ( PAI-1 ) gene may vary degree bleed . PAI-1 inhibits transformation plasminogen plasmin thereby decrease plasmin-induced fibrinolysis . Thus , PAI-1 promote clot stability PAI-1 polymorphism affect degree bleed response TXA craniosynostosis surgery .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Craniosynostoses</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Infants age 2 month 2 year undergoing anterior cranial vault reconstruction Known bleed disorder may increase risk bleed Current antifibrinolytic therapy patient may bleed less Patient family history thromboembolic disease may potential risk thrombosis Use NSAIDS within 5 day surgery may increase risk bleed Known allergy TXA History renal insufficiency TXA renally excrete Acquired colour vision defect one first sign long term TXA toxicity colour vision disturbance .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Blood Loss Transfusion</keyword>
	<keyword>Craniosynostoses</keyword>
	<keyword>Tranexamic Acid</keyword>
	<keyword>Children</keyword>
</DOC>